"Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes"
"Conclusions and Relevance Pioglitazone use was not associated with a statistically significant increased risk of bladder cancer, although an increased risk, as previously observed, could not be excluded. The increased prostate and pancreatic cancer risks associated with ever use of pioglitazone merit further investigation to assess whether they are causal or are due to chance, residual confounding, or reverse causality."
https://jama.jamanetwork.com/article.aspx?articleid=2397834
No comments:
Post a Comment